Company · CIK 1723128
Amneal Pharmaceuticals, Inc.
| CIK | 1723128 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Listed | AMRX (Nasdaq) |
| First annual or quarterly report | 2018-03-09 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298741 | 2026-09-03 | 2026-09-03 | 1 | |
| 333-263225 | 2022-03-02 | 2023-11-14 | 3 | |
| 333-263226 | 2022-03-02 | 2023-11-14 | 3 | |
| 333-230022 | 2019-03-01 | 2019-03-01 | 1 | |
| 333-224702 | 2018-05-07 | 2018-05-09 | 3 | |
| 333-223501 | 2018-03-07 | 2018-05-07 | 3 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-03 | S-3ASRShelf registered | 333-298741 | 0001140361-26-035617 |
| 2023-11-14 | EFFECTDeclared effective | 333-263226 | 9999999995-23-003319 |
| 2023-11-14 | EFFECTDeclared effective | 333-263225 | 9999999995-23-003318 |
| 2023-03-24 | EFFECTDeclared effective | 333-263226 | 9999999995-23-000656 |
| 2023-03-24 | EFFECTDeclared effective | 333-263225 | 9999999995-23-000655 |
| 2022-03-02 | S-3ASRShelf registered | 333-263226 | 0001193125-22-062996 |
| 2022-03-02 | S-3ASRShelf registered | 333-263225 | 0001193125-22-062990 |
| 2019-03-01 | S-3ASRShelf registered | 333-230022 | 0001193125-19-061022 |
| 2018-05-09 | EFFECTDeclared effective | 333-224702 | 9999999995-18-001197 |
| 2018-05-09 | S-1/AAmendment | 333-224702 | 0001193125-18-157112 |
| 2018-05-07 | S-1Registration filed | 333-224702 | 0001193125-18-153798 |
| 2018-05-07 | RWWithdrawn | 333-223501 | 0001193125-18-153738 |
| 2018-04-13 | S-1/AAmendment | 333-223501 | 0001193125-18-116990 |
| 2018-03-07 | S-1Registration filed | 333-223501 | 0001193125-18-073686 |
| 2018-02-09 | EFFECTDeclared effective | 333-221707 | 9999999995-18-000388 |